Brown-Forman rated new Buy at CitigroupBF.B was initiated with a Buy rating, Citigroup said. $67 price target. Company's is positioned to see accelerating sales growth.
Cisco Systems rated new Equal-weight at Morgan StanleyCSCO was initiated with an Equal-weight rating, Morgan Stanley said. Market share losses could offset growth from new ventures.
Genzyme General downgraded at BarclaysGENZ downgraded to Equal Weight from Overweight and price target cut to $52 from $63. Persistent Overhang on consent Decree, Barclays said. 2010 and 2011 EPS estimates lowered to $2.31 and $3.68, respectively.
Generac initiated at BofA/MerrillGNRC coverage initiated with a Neutral rating and $17 price target, Bank of America/Merrill Lynch said. Attractive growth story at fair value, mentioned analysts.
Generac rated new Neutral at GoldmanGNRC was initiated with a Neutral rating, Goldman Sachs said. $17 price target. Company has dominant market share in the residential market and generates significant free cash flow.
Juniper Networks rated new Overweight at Morgan StanleyJNPR was initiated with an Overweight rating, Morgan Stanley said. $37 price target. Ethernet switching market should drive sales and earnings growth.
RTI International Metals downgraded at BofA/MerrillRTI downgraded to Underperform from Neutral. Valuation call, Bank of America/Merrill Lynch said. Price target raised to $32 from $24. Maintain 2010 and 2011 EPS estimates at -$0.60 and $0.30, respectively.
Safe Bulkers reinstated at BofA/MerrillSB coverage reinstate with a Buy rating and $9.50 target. Dry bulker with strong charters, Bank of America/Merrill Lynch said.
Westlake Chemical upgraded at JP MorganWLK upgraded at JP Morgan. Rating raised to Overweight from Neutral. Price target raised to $28 from $21. Maintains 2010 EPS estimates of $1.50.
ADM price target lowered to $34 from $37 as ethanol sentiment is driving stock weakness, Bank of America/Merrill Lynch said. 2010 and 2011 EPS estimates both lowered to $2.90. Maintain Buy rating.
Apollo Group target, estimates higher at BofA/Merrill
APOL 2010 and 2011 EPS estimates increased to $5.10 and $5.93, respectively. Strategic shift continues, Bank of America/Merrill Lynch said. Price target raised by a dollar to $69. Maintain Neutral rating.
Apollo Group target, estimates higher at BofA/MerrillAPOL 2010 and 2011 EPS estimates increased to $5.10 and $5.93, respectively. Strategic shift continues, Bank of America/Merrill Lynch said. Price target raised by a dollar to $69. Maintain Neutral rating.
Apollo estimates lowered at UBSAPOL estimates were cut through 2011, UBS said. Company lowered guidance. Buy rating and $120 price target.
Avnet estimates, target raised at UBSAVT estimates were increased through 2011, UBS said. Company pre-announced earnings and should also benefit from the BELM acquisition. Buy rating and new $35 price target.
Chubb estimates lowered at UBSCB estimates were reduced through 2011, UBS said. Company is seeing higher catastrophe losses. Buy rating and $56 price target.
Celgene target boosted at CitigroupShares of CELG now seen reaching $72, Citigroup said. Company could deliver higher Revlimid growth in Europe. Buy rating.
FMC Corp. target raised at UBSFMC target was increased to $70, according to UBS. Higher spot commodity prices are helping contract pricing. Buy rating.
Google estimates boosted at UBSGOOG estimates were raised through 2011, UBS said. Channel checks are showing positive keyword pricing. Buy rating and $700 price target.
Goldman Sachs estimates boosted at BarclaysGS 2010 and 2011 EPS estimates improved to $18.28 and $20.23, respectively. Raising out FICC and principal investment gains estimates, Barclays said. Maintain Equal weight rating and $95 price target.
Jabil Circuit target, estimates boosted at Credit SuisseJBL price target increased to $18.60 from $17 after strong 2Q10 results and strong 3Q10 guidance, Credit Suisse said. 2010 and 2011 EPS estimates raised to $1.32 and $1.75, respectively. Neutral rating.
Mead Johnson numbers increased at CitigroupMJN estimates were raised through 2012, Citigroup said. Company is growing market share and the developing markets outlook is robust. Buy rating and new $60 price target.
Morgan Stanley estimates cut at BarclaysMS 2010 and 2011 EPS estimates trimmed to $2.43 and $3.33, respectively. Barclays noted weaker trading revenues. Reiterate Equal Weight rating and $34 target.
Micron estimates upped at UBSMU estimates were increased through 2011, according to UBS. Strong demand should drive higher near-term results. Neutral rating and $10.50 price target.
Netflix estimates, target boosted at FBRShares of NFLX now seen reaching $85, according to FBR Capital Markets. Estimates also raised, as the company should continue to deliver subscriber and margin growth. Outperform rating.
Nvidia estimates, target raised at CitigroupShares of NVDA now seen reaching $24, according to Citigroup. Estimates were also boosted, following positive channel checks. Buy rating.
Research in Motion estimates increased at KaufmanRIMM estimates were boosted through 2011, Kaufman Bros. said. Company will likely post strong earnings, driven by sales of the Curve and Bold devices. Buy rating.
Weyerhaeuser estimates higher at BarclaysWY 2010 and 2011 EPS estimates jumped to $1.20 and $2.75 on logs, wood, and pulp, Barclays said. Reiterate $70 price target and Overweight rating.
